Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Benzamidine is a small molecule serine protease inhibitor primarily used to relieve painful and inflammatory conditions of the oral cavity, such as infections and gingivitis. It acts as a reversible competitive inhibitor of trypsin, trypsin-like enzymes, thrombin, plasmin, and other serine proteases. Benzamidine is also widely used in biochemical research to prevent proteolytic degradation during protein purification and crystallography. Its mechanism involves inhibition of serine protease activity by binding to the active site of these enzymes[1][3][5]. The compound has also been studied for antiviral effects in derivatives against influenza virus infection[6].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Benzamidine.